Apr 29, 2019 9:45 am EDT BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders
Feb 27, 2019 9:45 am EST BioRestorative Therapies Announces the Creation of a Disc Advisory Committee
Nov 15, 2018 9:45 am EST BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States
Oct 18, 2018 9:45 am EDT BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer
Sep 24, 2018 9:45 am EDT BioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania
Aug 15, 2018 10:20 am EDT BioRestorative Therapies Announces Publication of Study Results Validating the Benefits of Using Hypoxic Cultured Cells to Treat Patients with Degenerative Disc Disease
Jul 25, 2018 9:45 am EDT BioRestorative Therapies Appoints Jason M. Lipetz, M.D. to its Scientific Advisory Board
Jun 11, 2018 9:45 am EDT BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program
May 7, 2018 9:45 am EDT BioRestorative Therapies Appoints Wayne J. Olan, M.D. as Clinical Director of Regenerative Disc/Spine Program
Jan 22, 2018 11:00 am EST BioRestorative Therapies Announces the Appointment of Adam D. Bergstein as Sr. VP, Planning and Business Development